UNSPSC 51182425: Butedronic acid

This classification denotes a bone resorption inhibitor and biphosphonate, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 26PB1U68YF. European Medicines Agency schedules Butedronic acid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06011MIG. Butedronic acid generally arises in the molecular formula C5H10O10P2.

The term BUTEDRONIC ACID is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 3, no. 3, 1989, list 29.) As of Q4 2014, BUTEDRONIC ACID remains the US FDA Preferred Term for this commodity. Butedronic acid bears US NLM identifiers UMLS ID C2347239 and NCI Concept Code C72092. SMILES: P(=O)(O)(O)C(P(=O)(O)O)C(CC(=O)O)C(=O)O.

UNSPSC 51182425 Butedronic acid is a Commodity code for a specific pharmaceutical active ingredient with minimal recent state and local procurement activity. No recent state and local contract opportunities were identified for this code.

The absence of solicitation activity under this code reflects the narrow, specialized nature of butedronic acid procurement — a bisphosphonate compound with limited therapeutic application that falls outside typical state and local purchasing patterns. State and local agencies do not routinely procure individual pharmaceutical active ingredients directly; procurement of medications typically flows through established drug distribution channels, hospital pharmacy systems, or state Medicaid formulary vendors rather than through open bidding on raw chemical compounds. This code shows no decision-relevant activity to pursue at this time.